Graff Fred 4
4 · Recro Pharma, Inc. · Filed Jan 4, 2018
Insider Transaction Report
Form 4
Graff Fred
Chief Commercial Officer
Transactions
- Award
Common Stock
2018-01-02+12,900→ 22,900 total - Award
Employee Stock Option (right to buy)
2018-01-02+25,800→ 25,800 totalExercise: $9.04Exp: 2028-01-02→ Common Stock (25,800 underlying)
Footnotes (2)
- [F1]All shares of common stock are represented by unvested restricted stock units that will vest in four equal annual installments beginning January 2, 2019, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
- [F2]The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.